Philipp Schatz

Global Regulatory Strategist – IVD at Bayer

Speaker

Dr. Philipp Schatz is a seasoned expert in precision medicine and in vitro diagnostics (IVD) with over 20 years of experience. Currently, he serves as the Global Regulatory Lead for IVD at Bayer, where he has spearheaded the development of regulatory strategies for oncology projects, achieving significant milestones such as the approval of Bayer's first companion diagnostic in the US and Japan.

Prior to his role at Bayer, Dr. Schatz was a Diagnostic Expert in AstraZeneca's Precision Medicine Unit and held various positions in CROs and the IVD industry. He has published over 20 peer-reviewed articles and is actively engaged in scientific committees, including the Precision Medicine Working Group of the EFPIA. Dr. Schatz holds a Doctor of Natural Sciences (Dr. rer. nat.) in Epigenetics from the University of Saarland. He is also a member of the Scientific Advisory Board for the PoC-ID Consortium, a work package leader for the BestAgeing consortium, and a member of both the European Society for Medical Oncology (ESMO) and the German Society of Cardiologists (DGK).